Condition: Cystic Fibrosis · Sponsor: University Hospital, Tours
Cystic fibrosis is an autosomal recessive inherited disease linked to various mutations in the gene coding for the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, with respiratory and digestive disorders conditioning the prognosis. Digestive damage may be responsible for malnutrition of multifactorial origin (insufficient energy intake, increased energy losses, increased basal metabolic rate), and studies show a correlation between reduced lean body mass and respiratory function. In 2019, the French National Authority for Health (HAS) redefined undernutrition by including "quantified reduction in muscle mass and/or function" as a phenotypic diagnostic criterion. Elexacaftor-Tezacaftor-Ivacaftor, an innovative therapy (authorization in 2021) for this population, aims to restore the function of CFTR protein. Significant improvements in lung function and weight gain were observed from the first weeks of treatment. These improvements have also led to the emergence of lesser-known nutritional problems in these patients, such as overweight and the development of metabolic complications. Nonetheless, new management options in terms of dietary adjustments and adapted physical activity for these patients are possible, given the development of their abilities. Adapted Physical Activity (APA) helps to improve general muscular function by strengthening respiratory and skeletal muscles, improving aerobic capacity, and aiding bronchial drainage through muscle streng…
This description comes directly from the study's public registry record.
Amelie GIBORY · 0247474747 · a.gibory@chu-tours.fr
Arnaud DE LUCA, MD · a.deluca@chu-tours.fr
Always discuss trial participation with your own doctor first.
| Cystic Fibrosis Resource and Competence Centre, University Hospital, Angers | Angers, France | Recruiting |
| Cystic Fibrosis Resource and Competence Centre, Fondation Ildys, Roscoff | Roscoff, France | Recruiting |
| Cystic Fibrosis Resource and Competence Centre, University Hospital, Tours | Tours, France | Recruiting |
| Cystic Fibrosis Resource and Competence Centre, Hospital, Tours | Vannes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06457451